{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:57:58Z","timestamp":1790837878804,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>ABO-incompatible (ABOi) kidney transplantation (KT) expands the kidney donor pool and may help to overcome organ shortage. Nonetheless, concerns about infectious complications associated with ABOi-KT have been raised.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In a nationwide cohort (Swiss Transplant Cohort Study), we compared the risk for infectious complications among ABOi and ABO-compatible (ABOc) renal transplant recipients. Infections needed to fulfill rigorous, prespecified criteria to be classified as clinically relevant. Unadjusted and adjusted competing risk regression models were used to compare the time to the first clinically relevant infection among ABOi-KT and ABOc-KT recipients. Inverse probability weighted generalized mixed-effects Poisson regression was used to estimate incidence rate ratios for infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>We included 757 living-donor KT recipients (639 ABOc; 118 ABOi) and identified 717 infection episodes. The spectrum of causative pathogens and the anatomical sites affected by infections were similar between ABOi-KT and ABOc-KT recipients. There was no significant difference in time to first posttransplant infection between ABOi-KT and ABOc-KT recipients (subhazard ratio, 1.24; 95% confidence interval [CI], 0.93-1.66; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.142). At 1 y, the crude infection rate was 1.11 (95% CI, 0.93-1.33) episodes per patient-year for ABOi patients and 0.94 (95% CI, 0.86-1.01) for ABOc-KT recipients. Inverse probability weighted infection rates were similar between groups (adjusted incidence rate ratio, 1.12; 95% CI, 0.83-1.52; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.461).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The burden of infections during the first year posttransplant was high but not relevantly different in ABOi-KT and ABOc-KT recipients. Our results highlight that concerns regarding infectious complications should not affect the implementation of ABOi-KT programs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004109","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:18:22Z","timestamp":1649168302000},"page":"1875-1883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study"],"prefix":"10.1097","volume":"106","author":[{"given":"C\u00e9dric","family":"Hirzel","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Projer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."},{"name":"Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Surial","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Manuel","sequence":"additional","affiliation":[{"name":"Transplantation Center and Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mombelli","sequence":"additional","affiliation":[{"name":"Transplantation Center and Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van Delden","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases Unit, Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Boggian","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Hygiene, Cantonal Hospital St, Gallen, St. Gallen, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N.","family":"Walti","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sidler","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Hadaya","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Geneva University Hospital, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dickenmann","sequence":"additional","affiliation":[{"name":"Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Hospital Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Binet","sequence":"additional","affiliation":[{"name":"Division of Nephrology\/Transplantation Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9la","family":"Golshayan","sequence":"additional","affiliation":[{"name":"Transplantation Center and Service of Nephrology, CHUV University Hospital, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen","family":"Huynh-Do","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Swiss Transplant Cohort Study (STCS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"key":"R2-20250604","first-page":"4538","article-title":"Present experiences in a series of 26 ABO-incompatible living donor renal allografts.","volume":"19","author":"Alexandre","year":"1987","journal-title":"Transplant Proc"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000000933","article-title":"Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and meta-analysis.","volume":"100","author":"Lo","year":"2016","journal-title":"Transplantation"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"e14050","DOI":"10.1111\/ctr.14050","article-title":"ABO-incompatible living kidney transplantation.","volume":"34","author":"Cen","year":"2020","journal-title":"Clin Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1093\/ndt\/gfr215","article-title":"Increase of infectious complications in ABO-incompatible kidney transplant recipients\u2014a single centre experience.","volume":"26","author":"Habicht","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000000029","article-title":"Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.","volume":"98","author":"Lentine","year":"2014","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis.","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/tri.13482","article-title":"Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption\u2014a retrospective study.","volume":"32","author":"Speer","year":"2019","journal-title":"Transpl Int"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfv388","article-title":"One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.","volume":"31","author":"Zschiedrich","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2020.01.152","article-title":"Outcome of ABO blood type-incompatible living-related donor kidney transplantation under a contemporary immunosuppression strategy in Japan.","volume":"52","author":"Hamano","year":"2020","journal-title":"Transplant Proc"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"e13591","DOI":"10.1111\/ctr.13591","article-title":"Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: a single-center Japanese cohort study.","volume":"33","author":"Kakuta","year":"2019","journal-title":"Clin Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10654-012-9754-y","article-title":"Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.","volume":"28","author":"Koller","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study.","volume":"71","author":"van Delden","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/TP.0000000000000457","article-title":"The reuse of immunoadsorption columns in ABO-incompatible kidney transplantation is efficient: the Swiss experience.","volume":"99","author":"Schiesser","year":"2015","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology.","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"suppl 4","key":"R21-20250604","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ajt.12124","article-title":"Urinary tract infections in solid organ transplantation.","volume":"13","author":"Parasuraman","year":"2013","journal-title":"Am J Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2008.580","article-title":"Rates of first infection following kidney transplant in the United States.","volume":"75","author":"Snyder","year":"2009","journal-title":"Kidney Int"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2215\/CJN.01790215","article-title":"Risk stratification for rejection and infection after kidney transplantation.","volume":"10","author":"Cipp\u00e0","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12916-015-0340-5","article-title":"Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis.","volume":"13","author":"Lafranca","year":"2015","journal-title":"BMC Med"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/dc05-2412","article-title":"The relationship between diabetes and infectious hospitalizations in renal transplant recipients.","volume":"29","author":"Lansang","year":"2006","journal-title":"Diabetes Care"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5414\/CNP58016","article-title":"Clinical aspects of renal transplantation in polycystic kidney disease.","volume":"58","author":"Stiasny","year":"2002","journal-title":"Clin Nephrol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"e14067","DOI":"10.1111\/ctr.14067","article-title":"Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for pneumocystis pneumonia prophylaxis.","volume":"34","author":"Fu","year":"2020","journal-title":"Clin Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/1475-6773.12182","article-title":"Methods for constructing and assessing propensity scores.","volume":"49","author":"Garrido","year":"2014","journal-title":"Health Serv Res"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management.","volume":"16","author":"Okumi","year":"2016","journal-title":"Am J Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.","volume":"393","author":"Scurt","year":"2019","journal-title":"Lancet"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/ajt.16316","article-title":"Quantifying infection risks in incompatible living donor kidney transplant recipients.","volume":"21","author":"Avery","year":"2021","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:01:11Z","timestamp":1749063671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004109","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}